ETROLIZUMAB

UNII: I2A72G2V3J
Preferred Substance Name: ETROLIZUMAB

1044758-60-2
ANTI-.BETA.7
ANTI-BETA7
ETROLIZUMAB [INN]
ETROLIZUMAB [USAN]
ETROLIZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.4.BETA.7/INTEGRIN .ALPHA.E.BETA.7) (HUMAN-RAT MONOCLONAL RHUMAB BETA7 HEAVY CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL RHUMAB BETA7 LIGHT CHAIN, DIMER
PRO145223
PRO-145223
RHUMAB .BETA.7
RHUMAB BETA7
RHUMABBETA7
RHUMAB-BETA7

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ETROLIZUMAB

Synonyms and Mappings

Resources

Note